Table 1.
IL-1 family antagonist expression, activity, and signaling.
Cytokine | Producing cell | Target cell | Receptor | Effect |
---|---|---|---|---|
IL-1Ra | Keratinocytes (89, 90, 94, 98–101) Infiltrating myeloid cells (89, 94) |
Keratinocytes Fibroblasts Myeloid cells |
IL-1R1 | Inhibition of IL-1 activity (94, 102, 111) |
IL-36Ra | Keratinocytes (103, 114–118) Myeloid cells (114, 115, 119, 120) |
Keratinocytes Myeloid cells CD4+ T cells |
IL-36R | Inhibition of IL-36 activity (121–124) |
IL-37 | Keratinocytes (103, 125–127) | Myeloid cells | IL-18Rα | Broad inhibition of pro-inflammatory signaling (128–132) |
IL-18RAP | Inhibition of IL-18 activity (133) | |||
IL-38 | Keratinocytes (103, 117, 118, 124, 134–136) | γδ T cells | TIGIRR-2 | Inhibition of IL-17A production (135) |
Myeloid cells | TIGIRR-2 IL-36R? |
Broad anti-inflammatory activity (50, 137) | ||
Keratinocytes | IL-36R? | Inhibition of IL-36γ activity (124) |
For each antagonist, the main producing cell type(s), target cells, receptors, and effects relevant to skin biology are listed. A comprehensive description of biological effects reported for each cytokine can be found in the text.